A landmark real-world study of more than 18,000 patients has demonstrated superior asthma control with the AeroChamber Plus* Flow-Vu* antistatic Valved Holding Chamber (VHC, or spacer) compared with other chamber devices.1 For those with asthma, particularly children, the choice of device to deliver their medication is an important consideration; even with the same metered-dose inhaler (MDI), not all valved holding chambers perform equally well.2 According to the study published in Pulmonary Therapy, the AeroChamber

Posted in News, Press, Published Studies, AeroChamber Plus* Flow-Vu* Chamber, asthma, COPD

Aerobika* device proves to be a cost-effective treatment option in the management of post-exacerbation COPD patients.

Posted in News, Aerobika*, COPD

Chronic Obstructive Pulmonary Disease (COPD) is a significant healthcare problem, with an estimated 384 million cases worldwide in 2010.1 Population aging is predicted to drive further growth, with one study forecasting a 150% increase in prevalence overall, and up to 220% in the 75 and over age group, between 2010 and 2030.

Posted in Press, News, COPD, AeroCount*, AEROECLIPSE*